Stockscreener 앱 받기
5.56
3.47%
-0.20
전일 마감가:
$5.76
열려 있는:
$5.79
하루 거래량:
135.86K
Relative Volume:
0.67
시가총액:
$203.16M
수익:
$18.81M
순이익/손실:
$-38.90M
주가수익비율:
-4.4566
EPS:
-1.2476
순현금흐름:
$-38.83M
1주 성능:
-7.49%
1개월 성능:
-3.05%
6개월 성능:
-17.63%
1년 성능:
+4.79%
1일 변동 폭
$5.54
$5.79
1주일 범위
$5.54
$6.25
52주 변동 폭
$4.80
$8.95
프로파운드 메디컬 Stock (PROF) Company Profile
명칭
Profound Medical Corp
전화
647-476-1350
주소
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Compare PROF vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
5.56 | 203.16M | 18.81M | -38.90M | -38.83M | -1.2476 |
ABT
Abbott Laboratories
|
103.70 | 179.44B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.41 | 122.04B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.15 | 117.81B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.69 | 66.22B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.07 | 51.34B | 6.30B | 1.07B | 1.09B | 1.8406 |
프로파운드 메디컬 Stock (PROF) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-07-27 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-07-23 | 개시 | Lake Street | Buy |
| 2024-07-16 | 업그레이드 | Stifel | Hold → Buy |
| 2023-11-28 | 개시 | Stifel | Hold |
| 2023-08-04 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-03-21 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-09-15 | 개시 | Jefferies | Buy |
모두보기
프로파운드 메디컬 주식(PROF)의 최신 뉴스
Profound Medical Corp. (TSX:PRN) Drops 4.47%: Capital Equipment Hospital Sales Cycles, TULSA-PRO Deployment Pacing, and Med-Tech Valuation Scrutiny Examined - kalkine.ca
Curaleaf Holdings Shares Retreat 5.79% as Cross-Border Takeover Scrutiny and Multi-State Pricing Pacing Weigh on Investor Sentiment - kalkine.ca
Does Profound Medical (PROF) Have the Potential to Rally 58.77% as Wall Street Analysts Expect? - Zacks Investment Research
Sexual function and continence outcomes separate treatments in Profound Medical (PROF)'s six-month trial. - Stock Titan
A prostate treatment passed technical tests on a less powerful MRI machine; patient use there is unproven. - Stock Titan
Can Profound Medical’s (TSX:PRN) Telix Pact Expand TULSA-PRO’s Reach? - Kalkine Media
First U.S. Brain Scan Doses Could Be A Game Changer For Telix Pharmaceuticals (ASX:TLX) - Simply Wall Street
Profound Medical Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga
Marjorie Taylor Greene Stock Trades and Disclosures - TechGraph
Daniel S Sullivan Stock Trades and Disclosures - TechGraph
Physician webinars are planned under Profound Medical (PROF) and Telix’s prostate care education pact. - Stock Titan
Profound, Telix Partner, Shares Up - Baystreet.ca
The companies plan to teach doctors how prostate scans complement MRI-guided treatment. - Stock Titan
Profound Medical Corp. and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care - www.marketscreener.com
Strength Seen in Profound Medical (PROF): Can Its 21.7% Jump Turn into More Strength? - Zacks Investment Research
Pacira BioSciences jumps 44% after Viatris agre... - Pluang
Raymond James reiterates Strong Buy on Profound Medical stock, $11 target - Investing.com Canada
Why is Profound Medical stock surging today? - Investing.com
Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue - The Manila Times
Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue - Investing News Network
Profound Medical (PROF) Projects Over 70% Gross Margin in Q3, Si - GuruFocus
Profound Medical stock surges 20% on raised Q3 revenue outlook - Investing.com
Small caps to watch: Earnings beats and misses, a dividend hike alongside a special payout, and more - The Globe and Mail
Profound Medical Reports Preliminary Q3 Revenue Above Street View; Shares Rise After-Hours - marketscreener.com
What's going on in today's after hours session - ChartMill
Gross margin is expected to top 70% as Profound Medical (PROF) previews preliminary Q3 revenue. - Stock Titan
Profound Medical Corp. Provides Earnings Guidance for the Third Quarter Ended September 30, 2026 - www.marketscreener.com
Devonian Health Group Stock Slides 12.50% as Delayed NYSE American Uplisting and Dilution Worries Weigh on Thykamine Developer (TSXV:GSD) - kalkine.ca
NN won about $130 million in annual new business over 12 months. The deal is expected to bring in about $50 million. - Stock Titan
Profound Medical And 2 Other Canadian AI Healthcare Stocks To Watch - Simply Wall Street
Green Thumb Industries Stock Slides as Regulatory Setback Fuels Cannabis-Sector Pressure and Downside Risk - kalkine.ca
The businesses behind the Knicks and Rangers are expected to split into two companies Oct. 26. - Stock Titan
UnitedHealth Group (NYSE:UNH) Stock: Sharply Better Medical Care Ratio Lifts Its 2026 Earnings Outlook - kalkine.ca
President of Profound Medical Richard Fabian Buys More Stock - simplywall.st
President of Profound Medical Richard Fabian Buys More Stock - simplywall.st
Profound Medical (TSX:PRN) Slides 11.92% as Bearish Pressure Builds: Can TULSA-PRO Momentum Offset Near-Term Weakness? - kalkine.ca
Profound Medical Stock Drops 11.92% as Investor Caution Builds Around Growth, Execution and Valuation - kalkine.ca
Why Profound Medical Corp stock plummeted yesterday - Wealth Awesome
(PRN) Strategic Equity Report (PRN:CA) - Stock Traders Daily
What's Going On With Profound Medical Corp Stock Monday? - Wealth Awesome
Profound Medical Stock And 2 Canadian AI Healthcare Stocks To Watch - Yahoo Finance
Profound Medical to Present at BIG10 Growth Conference - TipRanks
Profound Medical (NASDAQ: PROF) plans one-on-one investor talks at BIG10 conference - Stock Titan
Profound Medical Corp. (PROF) Peer Comparison – Compare with Others - Value Research
Profound Medical to Participate in Lake Street's 10th Annual Best Ideas Growth Conference - Investing News Network
Profound Medical Corp. to Present at Lake Street Capital Markets BIG10 Conference on September 10 - kalkine.ca
Profound Medical Names Richard Fabian as New President - TipRanks
Profound Medical names Richard R. Fabian as President; Mathieu Burtnyk becomes CTO - TradingView
New Profound Medical (PROF) president set for $550,000 salary plus stock awards - Stock Titan
A medical device company will meet investors in New York. No webcast will be available. - Stock Titan
프로파운드 메디컬 (PROF) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.18%
0.85%
자본화:
|
볼륨(24시간):